ARTICLE | Clinical News
NI-0501: Phase II amended
March 23, 2015 7:00 AM UTC
Novimmune amended an ongoing open-label, international Phase II trial of IV NI-0501 to include patients not previously treated with the standard of care. The trial was enrolling patients who have eith...